U.S. authorities subpoena GSK regarding diabetes drug Avandia

10/21/2010 | Wall Street Journal, The

GlaxoSmithKline has received a subpoena from the Justice Department and "civil investigative demands" from state authorities concerning the development and marketing of diabetes treatment Avandia. "These inquiries are at an early stage, and GSK is cooperating with these offices," the drugmaker said.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY